Prosecution Insights
Prosecution Insights
7 pending office actions • 5 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (14%) |
| §103 only | 3 (43%) |
| Double-patenting + other | 2 (29%) |
| Multi-statute (no §101) | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KU, SI MING | 1 | 72.7% | +32.9% |
| HOPKINS, SAMANTHA LAKE | 1 | 55.3% | +63.4% |
| BERA, HENA RAKESHKUMAR | 1 | — | — |
| LEVERETT, MARY CHANG | 1 | 61.1% | +22.9% |
| COUNTS, GARY W | 1 | 59.0% | +29.8% |
| HOWELL, THEODORE R | 1 | 66.7% | +25.5% |
| DARPOLOR, JOSEPHINE KEBBEH | 1 | 64.5% | +37.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18571892 | METHODS FOR DIAGNOSING A CANCER- OR ANTIBIOTICS-INDUCED DYSBIOSIS AND THEIR USE FOR IMPROVING CANCER TREATMENT BY IMMUNOTHERAPY | BERA, HENA RAKESHKUMAR | — |
| 18044008 | ANTI-ARGONAUTE PROTEIN AUTOANTIBODIES AS BIOMARKERS OF AUTOIMMUNE NEUROLOGICAL DISEASES | COUNTS, GARY W | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18784828 | STATISTICAL METHODS AND SYSTEMS FOR DETECTING PERFORATIONS DURING SURGICAL DRILLING BASED ON SENSED ELECTRICAL CHARACTERISTICS | KU, SI MING | 117d overdue |
| 17791549 | MULTISPECIFIC ANTIBODIES THAT BIND BOTH MAIT AND TUMOR CELLS | DARPOLOR, JOSEPHINE KEBBEH | 78d overdue |
| 17910385 | METHOD FOR TREATING CHRONIC KIDNEY DISEASES | HOWELL, THEODORE R | 72d |
| 18573728 | COMPOSITIONS AND METHODS FOR PERMEABILIZING THE BLOOD BRAIN BARRIER | HOPKINS, SAMANTHA LAKE | — |
| 18510726 | METHOD FOR IDENTIFYING PERSONALIZED THERAPEUTIC STRATEGIES FOR PATIENTS AFFECTED WITH A CANCER | LEVERETT, MARY CHANG | — |
| 18044008 | ANTI-ARGONAUTE PROTEIN AUTOANTIBODIES AS BIOMARKERS OF AUTOIMMUNE NEUROLOGICAL DISEASES | COUNTS, GARY W | — |
| Art Unit | Apps |
|---|---|
| 3775 | 1 |
| 1687 | 1 |
| 1678 | 1 |
| 1628 | 1 |
| 1642 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18784828 | STATISTICAL METHODS AND SYSTEMS FOR DETECTING PERFORATIONS DURING SURGICAL DRILLING BASED ON SENSED ELECTRICAL CHARACTERISTICS | KU, SI MING | 3775 | §103 | Final Rejection | 117d overdue | Pending | Jul 25, 2024 |
| 18573728 | COMPOSITIONS AND METHODS FOR PERMEABILIZING THE BLOOD BRAIN BARRIER | HOPKINS, SAMANTHA LAKE | — | §103 | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18571892 | METHODS FOR DIAGNOSING A CANCER- OR ANTIBIOTICS-INDUCED DYSBIOSIS AND THEIR USE FOR IMPROVING CANCER TREATMENT BY IMMUNOTHERAPY | BERA, HENA RAKESHKUMAR | — | §101§103§112 | Non-Final OA | — | Pending | Dec 19, 2023 |
| 18510726 | METHOD FOR IDENTIFYING PERSONALIZED THERAPEUTIC STRATEGIES FOR PATIENTS AFFECTED WITH A CANCER | LEVERETT, MARY CHANG | 1687 | DPOther | Final Rejection | — | Pending | Nov 16, 2023 |
| 18044008 | ANTI-ARGONAUTE PROTEIN AUTOANTIBODIES AS BIOMARKERS OF AUTOIMMUNE NEUROLOGICAL DISEASES | COUNTS, GARY W | 1678 | §102§103§112 | Non-Final OA | — | Pending | Mar 03, 2023 |
| 17910385 | METHOD FOR TREATING CHRONIC KIDNEY DISEASES | HOWELL, THEODORE R | 1628 | DPOther | Final Rejection | 72d | Pending | Sep 09, 2022 |
| 17791549 | MULTISPECIFIC ANTIBODIES THAT BIND BOTH MAIT AND TUMOR CELLS | DARPOLOR, JOSEPHINE KEBBEH | 1642 | §103 | Non-Final OA | 78d overdue | Pending | Jul 08, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial